| Factor Information | |
|---|---|
| Data ID | 307 |
| Factor | surfactant administration |
| Description | N/A |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | pregnancies with CCHD and their child |
| p Value | <0.001 |
| Conclusion | Neonates born with CCHD were more likely to be admitted to the neonatal intensive care unit, require hospital transfer after birth, have lower 5-minute Apgar scores, receive assisted ventilation, surfactant, or antibiotics within the newborn period, and to not survive the neonatal period or first year of life. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 437 |
| CHD Type | isolated CHD |
| CHD Subtype | C-CHD |
| Reference | |
|---|---|
| PMID | 30372776 |
| Year | 2019 |
| Title | Obstetric Outcomes Associated with Fetal Cyanotic Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | birth record | |
| Region | America, Ohio | |
| Method | Multivariate logistic regression | |
| Race | American | |
| Disease History | CCHD | |
| Treatment History | N/A | |
| Group | CCHD pregnancies(Treatment) | non-CCHD pregnancies(Control) |
| Number | 836 | 1424372 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.029 | 0.005 |
